-
Mashup Score: 0FDA Clears GlutenID Test for Easier Celiac Screening - 4 day(s) ago
Targeted Genomics’ GHR test uses NGS to detect genetic variants in genomic DNA isolated from at-home collected saliva samples.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The #FDA has approved the expanded label for avacincaptad pegol intravitreal solution (IZERVAY) for the treatment of geographic atrophy (GA), extending the approved dosing beyond 12 months. 🔗https://t.co/MmVeyJFbIO #GeographicAtrophy #FDANews https://t.co/avEG9kXmUx
-
-
Mashup Score: 0
Female dialysis patients had a greater risk of infection- and withdrawal-related mortality, while men were more likely to die from cardiovascular disease and cancer.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
New research is shedding light on sex-based differences in mortality among patients receiving maintenance #dialysis for end-stage kidney disease. Learn more: https://t.co/GyNhcS2tH6
-
-
Mashup Score: 0
In this episode, James Q. Del Rosso, DO, joins The Medical Sisterhood for a conversation about empowerment and the benefits of female role models.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
🚨Check out the latest #MedicalSisterhood episode with Drs. Mona Shahriari and James Del Rosso! https://t.co/lAOqTtnSzr
-
-
Mashup Score: 0
A study found a 6-injection subcutaneous immunotherapy, Grass MATA MPL improves rhinitis quality of life by 27.7% and stimulates broad immune responses.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
A game-changer in allergy immunotherapy? The phase 3 G306 trial shows Grass MATA MPL significantly reduces grass pollen allergy symptoms (20.3%) and improves quality of life (27.7%) with just 6 injections. https://t.co/Zs28oAzzZF
-
-
Mashup Score: 0Diagnosing and Managing Pediatric Functional Constipation - Functional Constipation (FC) Management - 4 day(s) ago
Discuss strategies to improve diagnosis of pediatric functional constipation (FC). Review current and emerging treatments for pediatric FC. Explore patient-centered management for pediatric
Source: fcmanagement.hcplive.comCategories: General Medicine News, General HCPsTweet-
Watch the iPub® Diagnosing and Managing Pediatric Functional Constipation: Strategies to Improve Diagnosis. https://t.co/eSmrzcWhdY https://t.co/9IdutLMVHy
-
-
Mashup Score: 0
These findings from the POETYK-PSO long-term extension trial point to a lack of new safety concerns in the first 5 years of using deucravacitinib for psoriasis.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
🚨In an announcement by Bristol Myers Squibb🚨 5-year results from the POETYK PSO long-term extension (LTE) trial demonstrating the durable safety profile of #deucravacitinib (Sotyktu) for adults with moderate-to-severe #psoriasis have been released. https://t.co/CBJkq3Jv2K https://t.co/pGmnbNpYuu
-
-
Mashup Score: 1Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD - 5 day(s) ago
Bruckner discusses her team’s long-term data on the safety and efficacy of birch bark extract, also known as Oleogel-S10, for those with epidermolysis bullosa.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
In a new interview🎥 The phase 3 EASE study on long-term use of birch triterpenes (Filsuvez) for #EpidermolysisBullosa was discussed. We interviewed Anna Bruckner, MD, of @ChildrensColo & @CUAnschutz, highlighting new research on this serious condition. https://t.co/MNgtvbClrP https://t.co/pRAhz5S7ec
-
-
Mashup Score: 0
Fifteen of 16 patients with chronic ulcers in a small study had positive patch test to common wound care products.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Chronic #ulcers can be worsened by contact #dermatitis from allergens in wound care products, necessitating updated diagnostic tests. Read more: https://t.co/3aGXPCirYe #AAAAI
-
-
Mashup Score: 0
The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The #FDA has approved the expanded label for avacincaptad pegol intravitreal solution (IZERVAY) for the treatment of geographic atrophy (GA), extending the approved dosing beyond 12 months. 🔗https://t.co/MmVeyJFbIO #GeographicAtrophy #FDANews https://t.co/avEG9kXmUx
-
The FDA has cleared Targeted Genomics' GlutenID test for saliva screening of #celiac disease. Read more: https://t.co/l6ZvJhUH45